Table 2.
The univariable logistic regression analysis of all-cause and cancer-specific early death.
| Characteristic | All-cause early death | Cancer-specific early death | ||||
|---|---|---|---|---|---|---|
| OR | 95% CI | P-value | OR | 95% CI | P-value | |
| Age | ||||||
| ≤55 | Reference | Reference | ||||
| 56–74 | 1.76 | 1.26, 2.49 | 0.001* | 1.64 | 1.17, 2.33 | 0.005* |
| ≥75 | 3.28 | 2.25, 4.84 | <0.001* | 3.06 | 2.09, 4.52 | <0.001* |
| Race | ||||||
| White patients | Reference | Reference | ||||
| African American | 1.10 | 0.75, 1.56 | 0.618 | 1.01 | 0.68, 1.46 | 0.967 |
| Others** | 1.11 | 0.74, 1.62 | 0.597 | 1.10 | 0.73, 1.61 | 0.651 |
| Insurance | ||||||
| Uninsured | Reference | Reference | ||||
| Insured | 0.60 | 0.35, 1.10 | 0.080 | 0.56 | 0.33, 1.03 | 0.048* |
| Unknown | 0.81 | 0.45, 1.53 | 0.502 | 0.78 | 0.43, 1.47 | 0.417 |
| Marital status | ||||||
| Unmarried | Reference | Reference | ||||
| Married | 0.89 | 0.64, 1.24 | 0.482 | 0.91 | 0.65, 1.29 | 0.602 |
| Divorced or Separated |
1.04 | 0.66, 1.61 | 0.873 | 1.13 | 0.71, 1.77 | 0.601 |
| Widowed | 1.95 | 1.36, 2.81 | <0.001* | 1.97 | 1.36, 2.88 | <0.001* |
| Unknown | 0.76 | 0.32, 1.58 | 0.492 | 0.83 | 0.35, 1.72 | 0.636 |
| Tumor size(mm) | ||||||
| ≤59 | Reference | Reference | ||||
| 60-105 | 1.55 | 1.17, 2.07 | 0.002* | 1.46 | 1.09, 1.96 | 0.011* |
| ≥106 | 2.88 | 2.06, 4.02 | <0.001* | 2.75 | 1.96, 3.86 | <0.001* |
| Histology grade | ||||||
| GI-II | Reference | Reference | ||||
| GIII-IV | 2.68 | 1.89, 3.91 | <0.001* | 2.85 | 1.97, 4.23 | <0.001* |
| Unknown | 2.78 | 1.82, 4.30 | <0.001* | 2.96 | 1.91, 4.66 | <0.001* |
| Histological classification | ||||||
| Endometrioid endometrial carcinoma | Reference | Reference | ||||
| Non-endometrioid endometrial carcinoma | 1.75 | 1.36, 2.24 | <0.001* | 1.76 | 1.37, 2.27 | <0.001* |
| Lymph node | ||||||
| No regional lymph node involvement | Reference | Reference | ||||
| Regional lymph node involvement | 1.41 | 1.10, 1.80 | 0.006* | 1.44 | 1.12, 1.85 | 0.005* |
| Bone-metastases | ||||||
| No | Reference | Reference | ||||
| Yes | 2.66 | 1.65, 4.21 | <0.001* | 2.89 | 1.79, 4.58 | <0.001* |
| Unknown | 1.16 | 0.89, 1.50 | 0.266 | 1.20 | 0.92, 1.56 | 0.181 |
| Brain-metastases | ||||||
| No | Reference | Reference | ||||
| Yes | 2.12 | 0.88, 4.63 | 0.073 | 2.26 | 0.93, 4.95 | 0.052 |
| Unknown | 1.07 | 0.84, 1.38 | 0.574 | 1.08 | 0.84, 1.40 | 0.534 |
| Liver-metastases | ||||||
| No | Reference | Reference | ||||
| Yes | 3.72 | 2.46, 5.57 | <0.001* | 3.81 | 2.50, 5.76 | <0.001* |
| Unknown | 1.20 | 0.92, 1.57 | 0.167 | 1.23 | 0.94, 1.62 | 0.129 |
| Lung-metastases | ||||||
| No | Reference | Reference | ||||
| Yes | 3.04 | 2.16, 4.26 | <0.001* | 3.11 | 2.20, 4.40 | <0.001* |
| Unknown | 1.47 | 1.11, 1.96 | 0.008 | 1.51 | 1.13, 2.03 | 0.006* |
| Surgery | ||||||
| No | Reference | Reference | ||||
| Yes | 0.14 | 0.11, 0.19 | <0.001* | 0.14 | 0.10, 0.18 | <0.001* |
| Radiation | ||||||
| No | Reference | Reference | ||||
| Yes | 0.22 | 0.13, 0.34 | <0.001* | 0.22 | 0.13, 0.34 | <0.001* |
| Chemotherapy | ||||||
| No | Reference | Reference | ||||
| Yes | 0.09 | 0.07, 0.13 | <0.001* | 0.09 | 0.07, 0.12 | <0.001* |
OR, odds ratio; CI, confidence interval; *p < 0.05; ** :American Indian/AK Native, Asian/Pacific Islander.